Back to Investors
Morningside Ventures

Morningside Ventures

Venture Capital

Founded in 1986 by the Chan family, Morningside is a technology and life science venture investment firm operating globally from offices in Boston, Shanghai and London.

Portfolio

2

companies


Portfolio companies

P

PsycApps

PsycApps develops evidence-based mental health games and digital platforms for young adults.

PhoreMost

PhoreMost

PhoreMost develops targeted therapies for cancer and age related conditions.


Team

NP

Neil Pegg

Representative

SB

Stephen Bruso

Digital Health and BioTech Partner


Recent investments

Seed
£1.5M

Morningside Ventures led the seed investment to help PsycApps expand its team and further develop its mental health game, eQuoo.

"After working in an NHS priory, I realised that my clients were reaching me way too late – often after six months on a waitlist and years after experiencing the first symptoms. I wanted to find a way to give them the skill set they needed before they needed it. If a student drops out of their course due to mental health issues, it will change their lives in a way that hurts them and society. With eQuoo we give young adults a tool that helps them grow mentally, stay mentally healthy and get help if they’re experiencing issues."
— Silja Litvin, Co-Founder and CEO
Series B
£33.0M

The financing round was led by BGF with participation from new and existing backers to support clinical development.

"We are thrilled to include this exceptional group of investors in PhoreMost’s Series B funding round. We are grateful for the continued support of existing investors and are delighted to welcome BGF, alongside strategic investors XtalPi with whom we have a highly valued ongoing research collaboration, and Astellas Venture Management."
— Chris Torrance, CEO